Tech Company Financing Transactions
ForteBio Funding Round
On 10/26/2005, ForteBio raised $17.3 million in Series B funding from The Vertical Group, Alloy Ventures and Latterell Venture Partners.
Transaction Overview
Company Name
Announced On
10/26/2005
Transaction Type
Venture Equity
Amount
$17,300,000
Round
Series B
Investors
The Vertical Group (Lead Investor) (Yue-Teh Jang)
Versant Ventures (Brian Atwood)
Proceeds Purpose
Company Information
Company Status
Acquired or Merged
Industry
Life Sciences
Mailing Address
1360 Willow Road 201
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
ForteBio is a venture-capital funded life science company developing analytical systems to provide rapid, real-time results for protein quantification and characterization of protein interaction.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joseph Keegan
Chief Financial Officer
Jack Fuchs
VP - Marketing
Christopher Silva
VP - Product Management
Robert Wicke
VP - Sales
Terry Salyer
Browse more venture capital transactions:
Prev: 10/26/2005: Ciclon Semiconductor Device venture capital transaction
Next: 10/27/2005: Truist venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs